Abstract
Although the incidence of gastric cancer (GC) is declining, it remains a significant global problem. GC is thought to arise via a series of histologically distinct premalignant stages and triggered by chronic Helicobacter pylori infection. Key to this pathway is intestinal metaplasia (IM), an intermediate stage immediately preceding dysplasia and a known risk factor in the progression to GC. This chapter focuses primarily on IM, its histological subtypes, clinical implications, and role in GC progression, and discusses the global surveillance and management guidelines for individuals with IM. The latter part of the chapter addresses the diagnosis and treatment of early GC which is a developing field in Western countries where GC is often diagnosed at an advanced stage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Research and Clinical Applications of Targeting Gastric Neoplasms
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
